Efficacy of Tranexamic Acid in Controlling Hemoptysis, A Randomized Control Trial (NCT02781597)
Hemoptysis
Postgraduate Institute of Medical Education and Research
The purpose of study is to evaluate the efficacy of tranexamic acid in controlling bleeding
in patients of hemoptysis and also to evaluate the safety of tranexamic acid.
- Drug: Tranexamic AcidPatients will receive Inj Tranexamic acid, in IV in a loading dose of 1 g over 10 min followed by an infusion of 1 g over 8 h in 500ml normal saline
- TA
- Drug: PlaceboPatients will receive 0.9% normal saline
- Placebo control
| Ages eligible for Study | 18 Years and older |
| Genders eligible for Study | All |
| Accepts Healthy Volunteers | No |
Inclusion Criteria:
- Acute ongoing hemoptysis
- Age: 18 years and above
Exclusion Criteria:
- Pregnant females
- Females on oral contraceptives
- Patients on antifibrinolytics
- Patients with known drug allergy
- Patients with renal failure
- Patients requiring intubation during study period
- Patients with Massive hemoptysis (>600 ml/24 hrs)
Hemoptysis is a common problem in India due to high incidence of tuberculosis and also due to post tubercular sequale. Hemoptysis is usually managed conservatively in mild to moderate cases and cases of massive hemoptysis are managed with more definitive treatment options like vessel embolization (bronchial/pulmonary artery) and surgery as a last option. Tranexamic acid is a antifibrinolytic used in many surgeries and trauma patients to control bleeding and it has been shown effective and safe. The purpose of the study is to evaluate the efficacy of tranexamic acid in patients with hemoptysis in controlling bleeding.
1 locations
India (1)
- Post graduate institute of medical education and researchNot specifiedChandigarh, UT, India, 160012
Status:
unknown
Type:
Interventional
Phase:
Ⅲ
Start:
31 December, 2010
Updated:
19 May, 2016
Participants:
66
